the issue was the scoping study fell short of expectation. It dragged Vmm down with it. Speculators like us will tolerate low Npv based on current spot prices with the hope that these are the lows and we expect it to be well north of these prices. Instos have a different criteria. The key now with Mei is to improve the feasibility with improvements in Mets and increase the ultra high grade resource component and increase the avg grade of lom.
not stating the obvious, but REE has stabilized and moved 3 percent in the last week. If this keeps improving, Mei would recover some lost ground. Further, this is the stretch of the progression curve where the sp tends to gradually drop before the recovery.
I’m sure Mei would have preferred a higher cr. However, one can only take what the market offers and the scoping study would have determined the amount raised and at what level.
- Forums
- ASX - By Stock
- MEI
- General discussion (MEI)
General discussion (MEI), page-5316
-
- There are more pages in this discussion • 298 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
Add MEI (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.002(1.61%) |
Mkt cap ! $218.3M |
Open | High | Low | Value | Volume |
9.4¢ | 9.7¢ | 9.1¢ | $419.8K | 4.450M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14130 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 81789 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 93952 | 0.094 |
6 | 380670 | 0.093 |
5 | 642908 | 0.092 |
9 | 368230 | 0.091 |
21 | 1437597 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 112596 | 9 |
0.097 | 73159 | 3 |
0.098 | 40000 | 1 |
0.099 | 89600 | 3 |
0.100 | 581404 | 9 |
Last trade - 15.49pm 10/10/2024 (20 minute delay) ? |
Featured News
MEI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online